- Home
- CPIX vs INMB Comparison
CPIX vs INMB Comparison
Compare CPIX & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPIX
- INMB
- Stock Information
- Founded
- CPIX 1999
- INMB 2015
- Country
- CPIX United States
- INMB United States
- Employees
- CPIX N/A
- INMB N/A
- Industry
- CPIX Biotechnology: Pharmaceutical Preparations
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- CPIX Health Care
- INMB Health Care
- Exchange
- CPIX Nasdaq
- INMB Nasdaq
- Market Cap
- CPIX 51.5M
- INMB 49.2M
- IPO Year
- CPIX 2009
- INMB 2019
- Fundamental
- Price
- CPIX $2.17
- INMB $1.52
- Analyst Decision
- CPIX
- INMB Hold
- Analyst Count
- CPIX 0
- INMB 3
- Target Price
- CPIX N/A
- INMB $4.30
- AVG Volume (30 Days)
- CPIX 46.5K
- INMB 330.3K
- Earning Date
- CPIX 11-04-2025
- INMB 10-30-2025
- Dividend Yield
- CPIX N/A
- INMB N/A
- EPS Growth
- CPIX N/A
- INMB N/A
- EPS
- CPIX N/A
- INMB N/A
- Revenue
- CPIX $41,278,349.00
- INMB $50,000.00
- Revenue This Year
- CPIX N/A
- INMB $191.43
- Revenue Next Year
- CPIX N/A
- INMB $12,299.51
- P/E Ratio
- CPIX N/A
- INMB N/A
- Revenue Growth
- CPIX 12.21
- INMB 19.05
- 52 Week Low
- CPIX $1.04
- INMB $1.53
- 52 Week High
- CPIX $7.25
- INMB $11.64
- Technical
- Relative Strength Index (RSI)
- CPIX 26.09
- INMB 31.09
- Support Level
- CPIX $1.96
- INMB $1.53
- Resistance Level
- CPIX $3.40
- INMB $1.69
- Average True Range (ATR)
- CPIX 0.21
- INMB 0.10
- MACD
- CPIX -0.13
- INMB -0.02
- Stochastic Oscillator
- CPIX 10.13
- INMB 2.22
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.